| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.4M | $13.3M | $65.4M |
| YoY Revenue Growth % | -67.2% | -79.7% | — |
| Gross Profit | -$12.5M | $6.3M | — |
| Gross Margin % | -50.0% | 47.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$54.2M | -$11.8M | -$26.1M |
| Operating Margin % | -80.0% | -80.0% | -39.9% |
| Net Income (GAAP) | -$85.6M | -$17.6M | -$32.2M |
| EBITDA (Normalized) | -$54.2M | -$11.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$16.3M | -$6.8M | -$1.8M |
| Capital Expenditures (CapEx) | $98.0K | $244.0K | — |
| Free Cash Flow (FCF) | -$16.4M | -$7.0M | -$1.8M |
| FCF Margin % | -80.0% | -52.7% | -2.7% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $32.5M | $899.0K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $67.9M | $6.4M | — |